• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国老年患者阻塞性睡眠呼吸暂停综合征合并肾功能不全对全因死亡率的影响:一项前瞻性队列研究

Effect of obstructive sleep apnoea syndrome combined with renal insufficiency on all-cause mortality in elderly patients in China: a prospective cohort study.

作者信息

Gao Yinghui, Fang Fengfeng, Zhang Zuo, Zhao Libo, Zhao Zhe, He Zijun, Li Kailiang, Bian Hongyan, Liu Lin

机构信息

Peking University International Hospital, Beijing, China.

Chinese PLA General Hospital, Beijing, China.

出版信息

BMJ Open. 2025 Jul 24;15(7):e086515. doi: 10.1136/bmjopen-2024-086515.

DOI:10.1136/bmjopen-2024-086515
PMID:40707151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12306263/
Abstract

OBJECTIVE

We hypothesised that all-cause mortality in elderly patients with obstructive sleep apnoea syndrome (OSAS) was associated with renal insufficiency.

DESIGN

A cohort study.

SETTING

A prospective study of patients with OSAS enrolled in sleep centres/departments in multicentre hospitals in China from 2015 to 2017.

PARTICIPANTS

A total of 1290 patients with OSAS from six tertiary comprehensive hospitals in China were included in this study; of these, 1076 patients were included in the analysis based on inclusion and exclusion criteria.

MAIN OUTCOME MEASURES

All-cause death events were the main adverse outcomes.

RESULT

During a median follow-up of 42 months, 50 patients (4.6%) died, including 24 (2.2%) cardiovascular deaths. The incidence of all-cause death and cardiovascular death was higher in patients with estimated glomerular filtration rate (eGFR) less than 30 mL/min/1.73 m than in the other groups (p<0.001). Multivariate Cox regression models showed that patients with low levels of eGFR had a higher risk of all-cause death compared with patients with high levels of eGFR (HR=8.954, 95% CI, 2.108 to 38.033; p=0.003) and cardiovascular death risk (HR=4.163, 95% CI, 1.524 to 11.375; p=0.005).

CONCLUSION

The incidence of all-cause death and cardiovascular death events increased with decreasing renal function in elderly patients with OSAS and was higher in patients with end-stage renal insufficiency. The risk of all-cause and cardiovascular deaths was highest at eGFR below 30 mL/min/1.73 m.

摘要

目的

我们推测老年阻塞性睡眠呼吸暂停综合征(OSAS)患者的全因死亡率与肾功能不全有关。

设计

一项队列研究。

背景

对2015年至2017年在中国多中心医院睡眠中心/科室登记的OSAS患者进行的前瞻性研究。

参与者

本研究纳入了来自中国六家三级综合医院的1290例OSAS患者;其中,根据纳入和排除标准,1076例患者纳入分析。

主要观察指标

全因死亡事件是主要不良结局。

结果

在中位随访42个月期间,50例患者(4.6%)死亡,其中24例(2.2%)为心血管死亡。估计肾小球滤过率(eGFR)低于30 mL/min/1.73 m²的患者全因死亡和心血管死亡的发生率高于其他组(p<0.001)。多变量Cox回归模型显示,与eGFR水平高的患者相比,eGFR水平低的患者全因死亡风险更高(HR=8.954,95%CI,2.108至38.033;p=0.003),心血管死亡风险更高(HR=4.163,95%CI,1.524至11.375;p=0.005)。

结论

老年OSAS患者的全因死亡和心血管死亡事件发生率随肾功能下降而增加,终末期肾功能不全患者的发生率更高。eGFR低于30 mL/min/1.73 m²时,全因和心血管死亡风险最高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2d4/12306263/d35e735efc77/bmjopen-15-7-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2d4/12306263/a8cf710884aa/bmjopen-15-7-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2d4/12306263/d35e735efc77/bmjopen-15-7-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2d4/12306263/a8cf710884aa/bmjopen-15-7-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2d4/12306263/d35e735efc77/bmjopen-15-7-g002.jpg

相似文献

1
Effect of obstructive sleep apnoea syndrome combined with renal insufficiency on all-cause mortality in elderly patients in China: a prospective cohort study.中国老年患者阻塞性睡眠呼吸暂停综合征合并肾功能不全对全因死亡率的影响:一项前瞻性队列研究
BMJ Open. 2025 Jul 24;15(7):e086515. doi: 10.1136/bmjopen-2024-086515.
2
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
3
Association of Homocysteine and Risks of Long-Term Cardiovascular Events and All-Cause Death among Older Patients with Obstructive Sleep Apnea: A Prospective Study.同型半胱氨酸与老年阻塞性睡眠呼吸暂停患者长期心血管事件和全因死亡风险的关系:一项前瞻性研究。
J Nutr Health Aging. 2022;26(9):879-888. doi: 10.1007/s12603-022-1840-6.
4
Tonsillectomy or adenotonsillectomy versus non-surgical management for obstructive sleep-disordered breathing in children.扁桃体切除术或腺样体扁桃体切除术与非手术治疗对儿童阻塞性睡眠呼吸障碍的疗效比较
Cochrane Database Syst Rev. 2015 Oct 14;2015(10):CD011165. doi: 10.1002/14651858.CD011165.pub2.
5
Non-invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea.无创正压通气治疗阻塞性睡眠呼吸暂停男性勃起功能障碍。
Cochrane Database Syst Rev. 2021 Sep 23;9(9):CD013169. doi: 10.1002/14651858.CD013169.pub2.
6
Blood pressure targets for hypertension in people with chronic renal disease.高血压合并慢性肾脏病患者的血压目标。
Cochrane Database Syst Rev. 2024 Oct 15;10(10):CD008564. doi: 10.1002/14651858.CD008564.pub3.
7
Non-invasive positive pressure ventilation for central sleep apnoea in adults.成人中枢性睡眠呼吸暂停的无创正压通气。
Cochrane Database Syst Rev. 2022 Oct 24;10(10):CD012889. doi: 10.1002/14651858.CD012889.pub2.
8
Adherence to Plant-Based Diets and Risk of CKD Progression and All-Cause Mortality: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.基于植物的饮食与慢性肾脏病进展和全因死亡率风险的关系:来自慢性肾功能不全队列(CRIC)研究的结果。
Am J Kidney Dis. 2024 May;83(5):624-635. doi: 10.1053/j.ajkd.2023.09.020. Epub 2023 Dec 14.
9
Pharmacological treatment for central sleep apnoea in adults.成人中枢性睡眠呼吸暂停的药物治疗。
Cochrane Database Syst Rev. 2023 Feb 27;2(2):CD012922. doi: 10.1002/14651858.CD012922.pub2.
10
Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes.用于慢性肾病和糖尿病患者的胰高血糖素样肽1(GLP-1)受体激动剂。
Cochrane Database Syst Rev. 2025 Feb 18;2(2):CD015849. doi: 10.1002/14651858.CD015849.pub2.

本文引用的文献

1
Prevalence of obstructive sleep apnea in whole spectrum chronic kidney disease patients: A systematic review and meta-analysis.全谱慢性肾脏病患者阻塞性睡眠呼吸暂停的患病率:系统评价和荟萃分析。
Sleep Med. 2024 Jul;119:526-534. doi: 10.1016/j.sleep.2024.05.047. Epub 2024 May 24.
2
Objective Sleep Duration and All-Cause Mortality Among People With Obstructive Sleep Apnea.客观睡眠时长与阻塞性睡眠呼吸暂停患者的全因死亡率。
JAMA Netw Open. 2023 Dec 1;6(12):e2346085. doi: 10.1001/jamanetworkopen.2023.46085.
3
Prevalence of obstructive sleep apnea in patients with chronic kidney disease: a hospital-based study.
慢性肾脏病患者阻塞性睡眠呼吸暂停的患病率:一项基于医院的研究。
Sleep Breath. 2023 Oct;27(5):1703-1708. doi: 10.1007/s11325-022-02764-2. Epub 2022 Dec 28.
4
Association of insomnia and short sleep duration, alone or with comorbid obstructive sleep apnea, and the risk of chronic kidney disease.单独或合并伴发阻塞性睡眠呼吸暂停的失眠和睡眠持续时间短与慢性肾脏病风险的相关性。
Sleep. 2022 Jul 11;45(7). doi: 10.1093/sleep/zsac088.
5
Risk of chronic kidney disease in patients with obstructive sleep apnea.阻塞性睡眠呼吸暂停患者的慢性肾脏病风险。
Sleep. 2022 Feb 14;45(2). doi: 10.1093/sleep/zsab267.
6
The Bidirectional Relationship Between Obstructive Sleep Apnea and Chronic Kidney Disease.阻塞性睡眠呼吸暂停与慢性肾脏病的双向关系。
J Stroke Cerebrovasc Dis. 2021 Sep;30(9):105652. doi: 10.1016/j.jstrokecerebrovasdis.2021.105652. Epub 2021 Feb 16.
7
Serum Cystatin C as a Potential Marker for Glomerular Filtration Rate in Patients with Cholangiocarcinoma.血清胱抑素C作为胆管癌患者肾小球滤过率的潜在标志物。
Int J Hematol Oncol Stem Cell Res. 2020 Jul 1;14(3):157-166. doi: 10.18502/ijhoscr.v14i3.3723.
8
A systematic review on the association between obstructive sleep apnea and chronic kidney disease.阻塞性睡眠呼吸暂停与慢性肾脏病关联的系统评价
Sleep Med Rev. 2020 Oct;53:101337. doi: 10.1016/j.smrv.2020.101337. Epub 2020 May 18.
9
Predictors of chronic kidney disease in obstructive sleep apnea patients.阻塞性睡眠呼吸暂停患者慢性肾脏病的预测因素
Multidiscip Respir Med. 2020 Jan 28;15(1):470. doi: 10.4081/mrm.2020.470.
10
Association of Sleep Apnea with Mortality in Patients with Advanced Kidney Disease.睡眠呼吸暂停与晚期肾病患者死亡率的关联。
Clin J Am Soc Nephrol. 2020 Feb 7;15(2):182-190. doi: 10.2215/CJN.07880719. Epub 2020 Jan 22.